human TFII-I, using lipofectamine 2000 (Invitrogen) . At 5 h after transfection medium was replaced and at 24 h after transfection cells were split 1:2. At 48 h after transfection H2K k -expressing cells were enriched by magnetic bead separation and incubated for an additional 24 h, at which time cell surface biotinylation was performed.
For surface biotinylation experiments involving induction of PLCγ expression, we used PC12 cell derivatives that express FLAG-tagged PLCγ under control of a doxycycline-off promoter-represssor system (18). Cells were grown on 10 cm For knockdown experiments, PC12 cells were grown as described above in 6-well plates and transfected at 80% confluency with a total volume of 1 ml Optimem medium Lipid binding assay. Membrane lipid strips (Echelon, P-6001) were blocked with 3% fatty acid-free BSA in TBS-T buffer (150 mM NaCl, 50 mM Tris, pH 8.0, 0.1% Tween-20) at RT for 1 h. The strips were then incubated with 3 µg of each GST-tagged construct at RT for 3 h. Membranes were washed in TBS-T buffer and subsequently incubated for 1 h at room temperature with a rabbit anti-GST antibody at 1:8000 dilution.
After subsequent washing in TBS-T, binding was detected with an enhanced chemiluminescence detection kit (Perkin-Elmer).
siRNA design. siRNA sequences were chosen using an algorithm available at the Dharmacon web site (www.dharmacon.com); the rat DNA target sequence was ACGGTGGAGGACTATTTCT and the human DNA target sequence was GTTACTCAGCCAAGAACGA. As a control we used the random sequence CGCGAUAAGAUGGCCUUCC. Oligonucleotides were obtained from Qiagen.
Calcium imaging. Free intracellular Ca +2 was measured as described previously (17). In brief, cells grown and transfected on coverslips were loaded with Fura-2/AM (Molecular Probes, Eugene, OR) at 1µg/ml in 1 ml per coverslip of a "cation-safe" solution (107 mM NaCl, 7.2 mM KCl, 1.2 mM MgCl 2 , 11.5 mM glucose, 20 mM HepesNaOH, pH 7.2), supplemented with 1 mM CaCl 2 and 0.1% BSA. Loading was carried out for 25 min at RT for HEK cells and for 40 to 60 min for PC12 cells. Incubation was continued for 15 min in the absence of Fura-2/AM to allow de-esterification. Coverslips were assembled in an open perfusion chamber and mounted in an inverted microscope (Nikon eclipse TS 100). Calcium recordings were taken using an XF73-2 filter and analyzed by InCytlm2 software. EYFP served as the transfection marker and was detected at excitation wavelength 485 nm. Fura2/AM emission at 505 nm was monitored with excitation at 340 and 380 nm. Intracellular calcium measurements represent 340/380 nm ratios obtained from groups of 40 -50 transfected cells.
After cells were mounted in the microscope they were washed once with cationsafe solution containing 0.1% BSA, allowed to rest for 30 sec, and then stimulated with 100 µM UTP (Invitrogen) or 5 µM Brk (Sigma). After 3 min stimulation in the absence of extracellular calcium, the medium was brought to 1 mM CaCl 2 and calcium entry was monitored for 3 min in the continued presence of agonist. All stimulations were performed at RT, and all displayed measurements are representative of at least nine independent experiments. Each trace represents the average 340/380 nm ratio for 40 -50 individual cells.
Immunoblotting. Transfected cells were lysed for 5 min at 95˚C in lysis buffer (60mM TrisCl [pH 7.6], 1% SDS). Aliquots (30 µg protein) were fractionated by 8% SDS-PAGE and immunoblotting was performed using anti-TFII-I antibody 3588 (14) at a 1:5000 dilution and an anti-neuronal tubulin antibody (Berkeley Antibody Company) at a 1:1000 dilution. For cell surface biotinylation experiments, mouse monoclonal anti-FLAG antibody M2 (Sigma) was used at 160 µg/ml and the mouse monoclonal antibody anti-Myc 9E10 was used at 1:500 dilution. For immunoprecipitation experiments, a mouse monoclonal anti-PLCγ-2 antibody (Santa Cruz) was used at 1:200 dilution, rabbit polyclonal antibody 3588 against TFII-I (14) was used at 1:5000 dilution and the antiphosphotyrosine antibody 4G10 (Upstate) was used at 1µg/ml.
Immunohistochemistry. Transfected cells, attached to coverslips, were fixed with 3% paraformaldehyde in 2 x PBS for 30 min and washed three times in 2 x PBS for 15 min. After quenching in 50mM NH 4 Cl for 15 min and three 15-min washes in 2 x PBS, cells were permeabilized for 1 hr in a solution containing 2 x PBS, 1% bovine serum albumin, 1% goat serum, and 0.075% w/v saponin. Coverslips were washed three times with 2 x PBS and then inverted over 250 µl of an anti-Myc antibody at a 1:250 dilution in a wet chamber overnight at 4˚C. Coverslips were washed three times in 2 x PBS and inverted over 250 µl of a secondary antibody solution at 1:300 dilution for 1 hr at RT. Finally, coverslips were washed three times in 2 x PBS and mounted into slides with Slofade containing DAPI. Fluorescence signals were detected with a Zeiss LSM410 confocal laser scanning microscope. Domain alignments. The GDDA was performed as described previously (6,21).
Briefly we modified the original target sequence hTFIIi (NP_001509.2), mTFIIi (AAC53569.1; data not shown), rTFIIi (AAO32679.1; data not shown) or hTFIIi IRD1 (NP_005676.2; data not shown), by inserting a portion (10 -50%; "seed") of the pfam domain sequence (PH domain, PF00169) at every amino acid position of the target sequence. The modified sequences were searched by rps-BLAST (settings E = 0.01, no filter) against the "seed" domain sequence and the percentages of coverage were plotted against each amino acid position. Pairwise alignments for the modified target sequence (hTFIIi) with 10-50% PH domain "seeds" (Red = N-terminal; Black = C-terminal) are shown in Fig. S2 . In data not shown, human, rat, and mouse TFIIi sequences exhibited the same pattern of hits in homologous regions, while TFIIi IRD1 failed to show any hits above 85% coverage for all PH domain inserts (10 -50%; "seed").
Assay for cell surface protein by biotinylation. Cells were washed three times with 10 ml PBS and subsequently incubated for 30 min at RT in 6 ml PBS containing 1mM sulfo-NHS-LC-biotin (Pierce). Reactions were quenched for 10 min with 10 ml PBS containing 10 mM Tris, 100 mM glycine. Cells were washed twice with 10 ml PBS and lysed on ice for 30 min in 500 µl RIPA buffer. Lysates were clarified by centrifugation at 13,000 g for 20 min and protein concentration was adjusted to 1 µg/µl in RIPA buffer. Streptavidin-agarose beads (50 µl of a 50:50 slurry) were added to 500 µl of adjusted cell lysate, containing 200 -500 µg protein and the suspension was rocked overnight at 4˚C. Beads were washed exhaustively with 1 ml RIPA buffer, boiled in 40 µl sample buffer and analyzed by immunoblotting. Rabbit polyclonal anti-TRPC3 antibody (6) was used at 1:1000 dilution. The cytosolic protein heme oxygenase-2 (HO2) was assayed as a negative control, using a rabbit polyclonal antibody (31). CD71 was assayed using a polyclonal antibody (Santa Cruz) as a positive control for cell surface labeling.
Yeast interaction assays. Assays employed the Matchmaker 3 yeast two-hybrid system (Clonetech). The yeast strain AH109 was transformed with rat PLC-γ1 fragments cloned into pGADT7 (β-gal acceptor domain) vector or human TFIIi fragments cloned into pGBKT7 (β-gal binding domain). Expression of protein fragments was determined by immunoblotting using anti-HA or anti-Myc antibodies, respectively. Positive yeast clones grew on minimal SD agar (Clonetech) lacking adenine, histidine, leucine, and tryptophan, and appeared blue on X-gal-containing plates.
Peptide affinity chromatography. Peptides were synthesized in the Johns Hopkins Biopolymers core facility and linked through cysteine to activated agarose gel beads (Pierce) at a coupling efficiency of 1 mg peptide/ml beads.
Cells were lysed for 30 min on ice in 1 ml of a buffer containing 1% NP40, 150mM NaCl, 25 mM TrisCl [pH 8.0], 1 mM Na 3 VO 4 , I mM Na 2 MoO 2 , 1mM phenylmethylsulfonyl fluoride and additional protease inhibitors (Roche) at one tablet per ml buffer. Lysates were clarified by centrifugation at 20,000 g for 20 min. Supernatants were pre-cleared at 4˚C by addition of 50 µl of a 50 % slurry of cysteine coupled beads and centrifugation at 500 g for 2 min. Clarified supernatants were incubated with 50 µl of a 50% slurry of peptide-coupled beads for 2 h at 4˚C. After washing with lysis buffer, beads were boiled in 50 µl of loading buffer to release bound protein, which was assayed by immunoblotting. This procedure was scaled-up 50 fold to produce sufficient protein for identification by mass spectroscopy. The protein yielded eight peptides, all of which were contained within the sequence of PLCγ-2: LAADSKEDAVNWLSGLK; LSFSDDIEQTMEEEVPQDIPPTELHHFGEK; YPVTPELLER; MYVDPSEINPSMPQRT; IQQYFPSNYVEDISTADFEELEK; GILDLNTYNVVK; RVEELFEWFQSIR; and VTFEIYDPNLAFLR.
Mutagenesis. Mutations were introduced using the QuickChange XL sitedirected mutagenesis kit (Stratagene), using human TFII-I isoform 4 as a template. To generate human TFII-IΔNLS, the nuclear localization sequence was deleted using mutagenic primers 5'-GATGATGATTATTCTAATGAGCTACCGCAG-3' (forward) and 5'-CTGCGGTAGCTCATTAGAATAATCATCATC-3' (reverse). PCR was carried out as follows: 1 cycle at 95˚C for 1 min; 18 cycles of 95˚C for 50 sec, 58˚C for 50 sec and 68˚C for 9 min 40 sec; 1 cycle at 68˚C for 7 min. To generate human TFII-IΔPHN, coding sequence encoding amino acid residues 303 -345 were deleted using primers 5'-GCCAATGCTGGGAAGTACCCTCTTTTCCAGTC-3' (forward) and 5'-GACTGGAAAAGAAAATACTTCCCAGCATTGGA-3' (reverse). PCR was performed as follows: 1 cycle at 95˚C for 1 min; 18 cycles of 95˚C for 50 sec, 52˚C for 50 sec and 68˚C for 9 min 40 sec; 1 cycle at 68˚C for 7 min. To generate TFII-IΔPHC, coding sequence encoding amino acid residues 375-427 were deleted using primers 5'-AGGCCATCTACTTACGGAATGGTGGATCAGCTTTTC-3' (forward) and 5'-GAAAAGCTGATCCACCATTCCGTAAGTAGATGGCCT-3' (reverse). PCR was performed as follows: 1 cycle at 95˚C for 1 min; 18 cycles of 95˚C for 50 sec, 52˚C for 50 sec and 68˚C for 9 min 40 sec; 1 cycle at 68˚C for 7 min. For generation of TFII-I(ΔPHN, YY/FF), a PHN deletion was introduced into a cDNA encoding TFII-I(YY357, 462FF) (17) as described above.
All mutations were confirmed by nucleotide sequencing.
GST fusion proteins. Intervals encoding the entire PH-like domain of TFII-I (codons 290 -440) or the linker region and PHC-like half-domain (codons 345-440)
were amplified by PCR and subcloned in-frame into pGEX-5X-1 (Amersham) between the BamH1 and Sal I restriction sites. GST fusion proteins were expressed in E. coli and purified by glutathione affinity chromatography.
Immunoprecipitation. Cells (1.5 X10 7 ) transferred to 1 ml of serum-free RPMI at 37˚C for 30 min; for B cell receptor stimulation, 18.5 µg of goat F(ab') 2 anti-human IgM (µ chain-specific, Jackson Labs) were added per ml. At various times cells were collected and lysed in 1 ml lysis buffer [1% NP40, 150mM NaCl, 25 mM TrisCl pH 8.0, 1 mM Na 3 VO 4 , I mM Na 2 MoO 2 , 1mM phenylmethylsulfonyl fluoride and protease in- 
